• 5-hme-dCTP: Precision Reagent for Plant Epigenetic DNA Resea

  2026-05-20

  5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) enables high-fidelity incorporation of hydroxymethylcytosine into DNA, supporting advanced studies in plant epigenetic DNA modification and gene regulation. APExBIO’s B8113 product achieves ≥90% purity and is validated for use in stress-response and DNA hydroxymethylation assays.

• Serum Proteomics Identifies HGFA as a Biomarker for PAH

  2026-05-19

  The study by Zhang et al. leveraged isobaric tag proteomics and Mendelian randomization to identify hepatocyte growth factor activator (HGFA) as a promising serum biomarker for pulmonary arterial hypertension (PAH). Their integrative approach demonstrates the diagnostic potential of HGFA and highlights new directions for noninvasive disease monitoring in PAH research.

• Y-27632 ROCK Inhibitor: Protocols and QC for Cytoskeletal St

  2026-05-19

  Y-27632 is a highly selective Rho-associated protein kinase (ROCK) inhibitor commonly used to modulate cytoskeletal dynamics in cell biology research. It is best employed for dissecting ROCK signaling pathway effects on cellular stress fiber formation and actin rearrangement, but should not be used where non-ROCK kinase inhibition or clinical applications are required. Researchers should rely on product specifications and established workflows for optimal results.

• Necrostatin-1: Precision RIP1 Kinase Inhibition in Necroptos

  2026-05-18

  Explore how Necrostatin-1, a potent RIP1 kinase inhibitor, advances necroptosis assays and inflammatory disease research. This article uniquely dissects assay optimization and cross-disease application, with practical insights for translational scientists.

• Technical Guide: Angiotensin I/II (1-5) for RAS Research Wor

  2026-05-18

  Angiotensin I/II (1-5) enables defined modeling of blood pressure regulation and aldosterone release in cardiovascular and renal research. It should not be used outside workflows focused on the renin-angiotensin system or peptide hormone vasoconstriction due to its specific mechanistic and solubility profile.

• RapaLink-1: Reliable mTORC1 Inhibition for Reproducible Assa

  2026-05-17

  This article offers a scenario-driven, evidence-based exploration of how RapaLink-1 (SKU A8764) addresses key laboratory challenges in cell viability and embryonic dormancy assays. By analyzing real-world questions from bench scientists and integrating current literature, it demonstrates the unique advantages of this third-generation mTOR inhibitor for reproducible, high-sensitivity workflows.

• Carboplatin: Platinum-Based DNA Synthesis Inhibitor in Oncol

  2026-05-16

  Carboplatin delivers robust, quantifiable control of DNA damage and tumor cell proliferation across ovarian and lung cancer models. This guide decodes advanced workflows, troubleshooting, and cutting-edge research to maximize Carboplatin’s impact in preclinical oncology studies.

• Topotecan HCl (SKU B2296): Reliable Antitumor Assay Solution

  2026-05-15

  Discover how Topotecan HCl (SKU B2296) addresses persistent challenges in laboratory cancer research. This scenario-driven article offers evidence-based insights on assay design, data interpretation, and vendor reliability, empowering researchers with validated workflows and robust performance metrics for Topotecan HCl.

• Cyclic Pifithrin-α Hydrobromide: Optimizing p53 Inhibitor Wo

  2026-05-15

  Cyclic Pifithrin-α hydrobromide stands out as a robust p53 inhibitor for dissecting apoptosis and DNA damage responses, offering unique protection from gamma irradiation and reducing cancer therapy side effects. This guide delivers evidence-based protocols, troubleshooting strategies, and practical insights for maximizing reproducibility and specificity in cellular and animal models.

• Hoechst 33342/PI Double Staining Kit: Assay Setup & Best Pra

  2026-05-14

  The Hoechst 33342/PI Double Staining Kit enables precise, fluorescent-based discrimination of viable, apoptotic, and necrotic cells by leveraging differential nuclear and membrane staining. It is optimized for research workflows requiring rapid assessment of cell death mechanisms, but is not suitable for diagnostic or clinical applications. Users should apply the kit within its validated research scope and follow established protocols for reliable results.

• EZ Cap™ Human PTEN mRNA (ψUTP): Applied Workflows & Troubles

  2026-05-14

  EZ Cap™ Human PTEN mRNA (ψUTP) enables high-efficiency, immune-evasive PTEN restoration for translational cancer research, especially in models of PI3K/Akt pathway-driven resistance. Explore optimized experimental workflows, data-backed troubleshooting, and the latest nanoparticle delivery insights to maximize reproducibility and impact in gene expression studies.

• Demethyleneberberine in Translational Research: Protocols &

  2026-05-13

  Demethyleneberberine (DMB) stands out as a multi-modal anti-inflammatory and neuroprotective agent, uniquely suited for precision modeling of disease pathways. This guide bridges advanced experimental setups, troubleshooting, and literature-backed best practices—empowering researchers to harness DMB’s full translational potential in inflammation, cancer, and neurodegeneration studies.

• Mitomycin C: Pathway-Specific Strategies for Precision Cance

  2026-05-13

  Explore the unique role of Mitomycin C as an antitumor antibiotic in pathway-specific cancer research. Uncover novel insights at the intersection of apoptosis signaling and immunotherapy, with in-depth analysis and protocol guidance distinct from existing resources.

• Resveratrol Inhibits EMT via Smad Signaling in Glioblastoma

  2026-05-12

  This study demonstrates that resveratrol suppresses epithelial-mesenchymal transition (EMT) and stem cell-like properties in glioblastoma (GBM) by modulating Smad-dependent signaling. The findings highlight the central role of TGF-β/Smad pathways in GBM invasiveness, suggesting new avenues for targeted research.

• Arachidonic Acid Supplementation Enhances Humoral Immunity

  2026-05-12

  This study demonstrates that dietary arachidonic acid (ARA) supplementation significantly accelerates the production of neutralizing antibodies in response to rabies vaccination, both in mice and human subjects. Through mechanistic dissection, the research reveals a key role of ARA metabolism within lymph nodes, providing actionable insights into immune modulation and vaccine adjuvant strategies.

705 records 18/47 page Previous Next First page 上5页 1617181920 下5页 Last page